The Patent Finder
US

Process for the Preparation of Pleuromutilins

US 9,120,727 In force
OverviewFamilyAssignmentsSources & methods

Term ends May 23, 2031 · High confidence

Filed Dec 12, 2012 as application 13/699,589 · Granted Sep 1, 2015
Base term, 20 years from filing
Today
20 years from filing
2011 2031
Clock starts
May 23, 2011
Term ends
May 23, 2031
Granted
Sep 1, 2015
base term fee events Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts May 23, 2011, when application PCT/AT2011/000237, the earliest non-provisional in its chain, was filed (this one was filed Dec 12, 2012)May 23, 2031High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderMay 23, 2031High confidence

Partial family

Application PCT/AT2011/000237PCT application
no patent term
no patent term
US 9,120,727this patent
May 2031
May 2031
Partial: 1 of the 2 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Dec 10, 2012
Reel 29439, frame 875
Riedl, Rosemarie; Heilmayer, Werner; Spence, LeeNabriva Therapeutics AGAssignment of Assignor's Interest
Sep 3, 2014
Reel 33659, frame 216
Nabriva Therapeutics AGKreos Capital IV (UK) LimitedLien
Nov 19, 2015
Reel 37093, frame 308
Kreos Capital IV (UK) LimitedNabriva Therapeutics AGRelease of Security Interest
Dec 2, 2015
Reel 37190, frame 424
Kreos Capital IV (UK) LimitedNabriva Therapeutics AGCorrective Assignment to Correct the Application No. in the Release by Secured Party from 12/699585 to 13/699585 Previously Recorded on Reel 037093 Frame 0308. Assignor(S) Hereby Confirms the Release Agreement.
May 17, 2018
Reel 47658, frame 862
Nabriva Therapeutics AGNabriva Therapeutics GmbHChange of Name
Dec 20, 2018
Reel 47973, frame 110
Nabriva Therapeutics GmbHHercules Capital, Inc.Intellectual Property Security Agreement
Jan 18, 2019
Reel 48062, frame 807
Nabriva Therapeutics GmbHHercules Capital, Inc.Security Interest
Mar 3, 2023
Reel 62881, frame 90
Hercules Capital, Inc.Nabriva Therapeutics GmbH; Zavante Therapeutics, Inc.Release of Security Interest
Mar 3, 2023
reel/frame not recorded
Hercules Capital, Inc.Nabriva Therapeutics GmbHRelease of Security Interest
Mar 3, 2023
reel/frame not recorded
Hercules Capital, Inc.Zavante Therapeutics, Inc.Release of Security Interest
Jun 20, 2023
Reel 64312, frame 350
Hercules Capital, Inc.Nabriva Therapeutics GmbHCorrective Assignment to Correct the Receiving Party Data and the Assignment Document Previously Recorded at Reel: 062881 Frame: 0090. Assignor(S) Hereby Confirms the Release of Security Interest.
Jan 9, 2025
Reel 69806, frame 458
Nabriva Therapeutics GmbHHong Kong King-Friend Industrial Company Ltd.Assignment of Assignor's Interest
Apr 3, 2025
Reel 70725, frame 291
Nabriva Therapeutics GmbHHong Kong King-Friend Industrial Company Ltd.Nunc Pro Tunc Assignment

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited